Dwyer Donald

CBO Dwyer buys 4.0K shares of VANI at $1.02; adds to 55.0K holdings while stock trades -53.2% from 52-week high amid -100.0% revenue decline.

Chief Business Officer Donald Dwyer purchased 4,000 shares at $1.02 on 2025-04-01, increasing his holdings from 51,000 to 55,000 shares. This buy occurs as VANI's stock has declined 53.2% from its 52-week high of $2.18 and fallen 8.1% over the past 30 days, yet Dwyer's prior four trades at this ticker were all well-timed at the 90-day mark. However, the fundamental backdrop is severely deteriorated: the company reported zero revenue in its latest quarter, a full-year net loss of $6,041,000, and a 100.0% annual revenue decline. Dwyer's four measurable prior purchases at VANI generated positive 90-day returns ranging from 2.6% to 5.7%, but the company's operational trajectory and current cash depletion present material questions about sustainability that transcend the predictive value of his historical timing pattern.

Chief Business Officer buys 1,000 shares at $1.11 despite stock down 74.4% from 52-week high and company unprofitable.

Dwyer Donald, the Chief Business Officer, purchased 1,000 shares of VANI at $1.11 on 2025-02-28, increasing his holdings from 50,000 shares to 51,000 shares. This purchase occurs in a deeply challenged operating environment: the company had $0.00 revenue in the latest quarter and a net loss of $-6,041,000.00 in its full fiscal year, with annual revenue down 51.0% year-over-year. The timing is also noteworthy relative to price action—at $1.08 currently, the stock trades -74.4% from its 52-week high of $4.22, and has declined 9.2% over the past 30 days and 23.4% over the past 90 days. However, Dwyer's execution history at this ticker specifically shows strong timing: his prior 5 purchases at VANI all registered positive 90-day returns, with results ranging from +2.6% to +5.7%, suggesting a pattern of buying ahead of recoveries. His broader cross-ticker buy track record of 13 prior transactions averaged +6.2% over 30 days and +2.9% over 90 days, with an 84.62% 90-day win rate. The juxtaposition of fundamental deterioration (collapsing revenue, ongoing losses) against both the insider's strong historical timing and a market already repriced sharply downward warrants investor scrutiny of what operational signals may be signaling a floor.

Chief Business Officer Donald Dwyer purchases 2,500 shares at $1.13-$1.14 over three days; stock down 73.5% from 52-week high amid revenue collapse and net losses.

Donald Dwyer, Chief Business Officer, made 3 separate purchases totaling 2,500 shares (2.5K shares) for $2,835.00 ($2.8K) between October 1–3, 2024, at prices ranging $1.13–$1.14. His holdings grew 5.3% to 50,000 shares (50.0K shares) post-transaction. The context is stark: Vivani Medical is trading at $1.12, down 73.5% from its 52-week high of $4.22, and the company reported zero revenue in its latest quarter with annual revenue down 51.0% year-over-year. Net income was $-5,356,000.00 ($-5.4M). Dwyer's prior purchases at VANI showed positive 90-day outcomes in 3 of 3 measurable cases, including an 18.8% 30-day gain and 11.5%–12.0% 90-day gains on two November 2023 purchases; more recently, July 2024 purchases posted 5.6%–6.5% 30-day returns. This filing reveals an executive purchasing stock during a severe market and fundamental deterioration, following a pattern of prior buys that subsequently appreciated—though those earlier gains occurred from substantially higher initial valuations and the company's operational trajectory has sharply contracted since.

CBOficially continues accumulation: Dwyer purchased 2,000 VANI shares at $0.96; now owns 38.5K shares, up 5.5%

Chief Business Officer Dwyer purchased 2,000 shares at $0.96 on 2023-11-22, adding to his 36.5K pre-transaction position in a company with -51.0% revenue decline and negative net income of $-6.0M. This represents his third open-market buy at VANI within consecutive days (2023-11-20, 2023-11-21, 2023-11-22). Among his five prior trades at this ticker, all three measurable buys delivered positive 90-day returns (+18.8%, +12.0%, +12.0%), reflecting well-timed entry points at prior moments. The current stock price of $1.21 sits -71.3% below the 52-week high and -32.0% down over 90 days from the purchase date, meaning the timing pattern observed in historical trades has not yet repeated. The sustained accumulation into a deteriorating fundamentals profile (latest quarterly revenue of $0.00) against price weakness merits investor scrutiny of management's rationale."

CBO Donald Dwyer buys 9,000 shares at $1.24 avg (2 transactions, $11.1K); stock down 71.3% from highs, 5 of 5 prior buys at VANI well-timed at 90d.

Donald Dwyer, Chief Business Officer, executed 2 open-market purchases totaling 9,000 shares at a blended average price of $1.24, increasing his holdings by 23.4% to 47,500 shares. The stock is currently $1.21, down -71.3% from its 52-week high of $4.22, and revenue has contracted 51.0% year-over-year while the company posted a net loss of $-6,039,000.00 in the latest quarter. Notably, all 5 of Dwyer's prior purchases at this ticker (dating back to September 2023) demonstrated well-timed 90-day outcomes, with cumulative 90-day gains ranging from +11.5% to +12.0%, suggesting a consistent pattern of buying before upswings regardless of prevailing sentiment or price momentum. The cumulative evidence—sustained accumulation by a senior executive during severe operational headwinds and valuation compression—requires scrutiny of whether the officer possesses non-public information about stabilization or turnaround prospects.